A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease (NAFLD). The randomized controlled trial published in The American Journal of Gastroenterology found that fecal transplants in patients with NAFLD result in a reduction in how easily pathogens and other unwanted molecules pass through the human gut and into circulation, known as intestinal permeability.
- Tool that more efficiently analyzes ocean color data will become part of NASA program
- Bearded seals are loud – but not loud enough
- A combination therapy for treating severe neurological childhood disorders
- Study identifies strengths and challenges of responding to dual disasters
- Diabetes patients use of mobile health app found to improve health outcomes, lower medical costs